These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Beardsley PM; Howard JL; Shelton KL; Carroll FI Psychopharmacology (Berl); 2005 Nov; 183(1):118-26. PubMed ID: 16184376 [TBL] [Abstract][Full Text] [Related]
3. The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats. Funk D; Coen K; Lê AD Brain Behav; 2014 May; 4(3):356-67. PubMed ID: 24944865 [TBL] [Abstract][Full Text] [Related]
4. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse. Jackson KJ; Carroll FI; Negus SS; Damaj MI Psychopharmacology (Berl); 2010 Jun; 210(2):285-94. PubMed ID: 20232057 [TBL] [Abstract][Full Text] [Related]
5. Species differences in the effects of the κ-opioid receptor antagonist zyklophin. Sirohi S; Aldrich JV; Walker BM Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699 [TBL] [Abstract][Full Text] [Related]
6. The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats. Deehan GA; McKinzie DL; Carroll FI; McBride WJ; Rodd ZA Pharmacol Biochem Behav; 2012 Jun; 101(4):581-7. PubMed ID: 22429993 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats. Beardsley PM; Pollard GT; Howard JL; Carroll FI Psychopharmacology (Berl); 2010 Jun; 210(2):189-98. PubMed ID: 20372878 [TBL] [Abstract][Full Text] [Related]
8. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors. Kissler JL; Walker BM Neuropsychopharmacology; 2016 Jan; 41(2):560-7. PubMed ID: 26105136 [TBL] [Abstract][Full Text] [Related]
9. The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors. Kissler JL; Sirohi S; Reis DJ; Jansen HT; Quock RM; Smith DG; Walker BM Biol Psychiatry; 2014 May; 75(10):774-82. PubMed ID: 23611261 [TBL] [Abstract][Full Text] [Related]
10. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis. Erikson CM; Wei G; Walker BM Neuropharmacology; 2018 Sep; 140():162-173. PubMed ID: 30075159 [TBL] [Abstract][Full Text] [Related]
11. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system. Gillett K; Harshberger E; Valdez GR Alcohol; 2013 Aug; 47(5):359-65. PubMed ID: 23731692 [TBL] [Abstract][Full Text] [Related]
12. Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors. Berger AL; Williams AM; McGinnis MM; Walker BM Neuropsychopharmacology; 2013 Mar; 38(4):647-54. PubMed ID: 23212453 [TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders. Domi E; Barbier E; Augier E; Augier G; Gehlert D; Barchiesi R; Thorsell A; Holm L; Heilig M Neuropsychopharmacology; 2018 Aug; 43(9):1805-1812. PubMed ID: 29463912 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic Relationships between Duration of Action of JDTic-like Kappa-Opioid Receptor Antagonists and Their Brain and Plasma Pharmacokinetics in Rats. Owens SM; Pollard GT; Howard JL; Fennell TR; Snyder RW; Carroll FI ACS Chem Neurosci; 2016 Dec; 7(12):1737-1745. PubMed ID: 27700049 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Carroll I; Thomas JB; Dykstra LA; Granger AL; Allen RM; Howard JL; Pollard GT; Aceto MD; Harris LS Eur J Pharmacol; 2004 Oct; 501(1-3):111-9. PubMed ID: 15464069 [TBL] [Abstract][Full Text] [Related]
17. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Knoll AT; Muschamp JW; Daws SE; Ferguson D; Dietz DM; Meloni EG; Carroll FI; Nestler EJ; Konradi C; Carlezon WA Biol Psychiatry; 2011 Sep; 70(5):425-33. PubMed ID: 21531393 [TBL] [Abstract][Full Text] [Related]
18. Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking. Funk D; Coen K; Tamadon S; Lê AD Int J Neuropsychopharmacol; 2019 Nov; 22(11):724-734. PubMed ID: 31556948 [TBL] [Abstract][Full Text] [Related]
19. The κ-opioid receptor antagonist JDTic decreases ethanol intake in alcohol-preferring AA rats. Uhari-Väänänen J; Raasmaja A; Bäckström P; Oinio V; Carroll FI; Airavaara M; Kiianmaa K; Piepponen P Psychopharmacology (Berl); 2018 May; 235(5):1581-1591. PubMed ID: 29492614 [TBL] [Abstract][Full Text] [Related]
20. Kappa-opioid receptor antagonism in the nucleus accumbens shell distinguishes escalated alcohol consumption and negative affective-like behavior from physiological withdrawal in alcohol-dependence. Lepreux G; Henricks AM; Wei G; Go BS; Erikson CM; Abella RM; Pham A; Walker BM Pharmacol Biochem Behav; 2024 Oct; 243():173840. PubMed ID: 39096973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]